Keyphrases
Multiple Sclerosis
100%
Progressive multiple Sclerosis
29%
Multiple Sclerosis Treatment
21%
India
16%
T Cells
16%
On-state Current
16%
Neurological Diseases
16%
Guillain-Barré Syndrome
16%
Magnetic Resonance Imaging
16%
Atrial Fibrillation
16%
Progressive MS
14%
Healthy Controls
13%
United States
12%
MS Patients
12%
Chronic Progressive
11%
Soluble interleukin-2 Receptor (sIL-2R)
9%
Corticosteroids
8%
Pharmacological Treatment
8%
Stroke Patients
8%
Immune Activation
8%
Stroke Prevention
8%
Immune Defense
8%
Lymphocyte Subsets
8%
Clinical Outcomes Research
8%
Corticosteroid Therapy
8%
Current Therapies
8%
High Risk
8%
Multiple Pregnancy
8%
Clinical Correlation
8%
Recurrent Stroke
8%
Patient Management
8%
First Clinical Demyelinating Event
8%
CHAMP
8%
Fracture Type
8%
Measles Vaccination
8%
Inducer
8%
Telemedicine
8%
Acute Stroke
8%
New Therapies
8%
Low-dose Steroids
8%
Sex Hormones
8%
Neopterin
8%
Environmental Exposure
8%
Quality of Care
8%
Movement Disorders
8%
Sham
6%
Measles Virus
6%
T Cell Activation
6%
Asian Patients
5%
Neuroscience
Multiple Sclerosis
81%
Magnetic Resonance Imaging
24%
T Cell
22%
Nervous System Disorder
16%
Magnetic Resonance Imaging
12%
Soluble Interleukin 2 Receptor
9%
Brainstem
9%
Cerebellum
9%
Immunotherapy
8%
Intravenous Immunoglobulin
8%
Sex Hormone
8%
Placebo
8%
Lymphocyte Subpopulation
8%
Pelvis
8%
Progesterone
8%
Guillain-Barre Syndrome
8%
Neopterin
8%
Evoked Potential
8%
Stereotypic Movement Disorder
8%
Diethylstilbestrol
6%
Cell Activation
6%
CD4
5%
Methylprednisolone
5%
Immunology and Microbiology
Multiple Sclerosis
75%
Low Drug Dose
18%
T Cell
16%
Prednisone
10%
Measles
10%
Immunity
8%
Rib
8%
Pregnancy
8%
Lifespan
8%
Magnetic Resonance Imaging
8%
T Cell Activation
8%
Intravenous Immunoglobulin
8%
Lymphocyte Subpopulation
8%
Natural Killer Cell
6%
CD4
5%
Lymphocytopenia
5%
B Cell
5%
CD3 Antigen
5%
Methylprednisolone
5%
